Business and Finance

A chat with Cardinal Health’s Joel Wayment, who dives into what can be done to help ensure that patients receive their necessary medications, no matter the conditions

The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector

Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden

Agreement provides pharma firms with an RWD and commercialization solution

Publication finds that only about 40% of retail pharmacists feel equipped to discuss biosimilars with patients

A conversation with Michael Abrams, co-founder and managing partner, Numerof & Associates

Examining the divestment risks, as more large companies look to spin off consumer health and other business units to focus on branded pharmaceuticals

Software firm merges with PharmaLex Group

Collaboration, the companies note, is expected to further engage patients

A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report

Grows Syner-G’s presence in RTP, a biotech hub that continues to develop

CDMO will use its BFS knowledge to support production out of its Kaysersberg, France plant

Acquires Medaxis, a patient engagement company

Merger with Phlexglobal expands provider’s technological capabilities

Integrated system intends to accelerate enrollment by strengthening relationship between hub patient services and providers

Partnership looks to ensure that chargebacks for suppliers are as accurate as possible

CellShip offers an alternative to cryopreservation, the parties note

Companies to focus on market access strategies

Newly acquired Performance Cell Manufacturing will now be known as Cellipont Bioservices

CDMO's new South Korean facility to offer a range of production services

With the delivery of Covid-19 booster shots in full swing, how does this effort compare to the initial vaccine distribution—and is the pharma supply chain adapting accordingly?

Acquisition of 86,000 square-foot plant has capability of manufacturing 1.8 billion capsules annually

Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces

Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C&GT sectors

Tufts analysis uncovers various benefits to conducting decentralized clinical trials—including financial benefits

Acquisition of AcKnowledge RS also expands company's IVD expertise

Partnership enhances CBM’s manufacturing capabilities in C&GT space

Syneos Health’s annual survey reveals the potential for shifts in the M&A space